Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : UCB Pharma S.A
Deal Size : Undisclosed
Deal Type : Licensing Agreement
UCB partners with Ailux Biologics, a Division of XtalPi, on Biologics AI Platform
Details : Under the licensing agreement, Ailux Biologics grants UCB a non-exclusive license to leverage XtalFold™ for the discovery and engineering of biologics.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
January 09, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : UCB Pharma S.A
Deal Size : Undisclosed
Deal Type : Licensing Agreement